When not if the EU approves Dacogen for MDS we should see some buying on SUPG. I see this approval shortly. With J&J in the corner they should have the means to get the right attention to approve. I believe it was announced that by Oct 12 production of Dacogen in the EU should be up and running. I believe that the current label allows for Dacogen to be sold already there, but approval would definitely add crediability. AML looks like the next step with the U.S. viewing results. The big potential for dacogen would be as a combination drug for other cancers. Once AML approval I believe we see several studies as a combination drug. Has anyone heard of any current studies where they may already studying this combined with another or several drugs?